Overview
Overview
Akira Pet MSCs are allogeneic UCT-WJ-MSCs specially processed for veterinary use. Unlike adipose or bone marrow-derived MSCs (the most common veterinary MSC sources), umbilical cord-derived MSCs are younger, more proliferative, and produce a richer immunomodulatory secretome — providing superior therapeutic outcomes for chronic inflammatory, degenerative, and autoimmune conditions in companion animals.
| Product Options |
|---|
| 10 Million Cells / 2 mL per vial |
| 25 Million Cells / 5 mL per vial |
Applications
Primary Veterinary Applications
- Osteoarthritis & Hip/Elbow Dysplasia — intra-articular MSC injection for joint regeneration
- Atopic Dermatitis & Allergic Skin Conditions — systemic immunomodulation
- Inflammatory Bowel Disease (IBD) — mucosal regeneration, anti-inflammatory
- Chronic Liver Disease & Hepatitis — hepatoprotective paracrine effects
- Kidney Insufficiency / CKD — renoprotective anti-fibrotic effects
- Cardiomyopathy — paracrine cardiac support
- Post-surgical Tissue Regeneration — accelerated healing
- Anti-Aging / General Wellness — vitality, immune optimization, senescent cell reduction
Evidence
Clinical Evidence (Veterinary)
Multiple veterinary clinical studies confirm MSC efficacy in canine OA: a 2022 blinded RCT of allogeneic MSC joint injection in 40 dogs demonstrated significant improvement in force plate gait analysis (affected limb peak vertical force increased 18%), pain assessment scores, and range of motion at 6-week follow-up — with no adverse immune reactions confirming safety of allogeneic UCT-derived MSCs in dogs.
For canine IBD (inflammatory bowel disease), IV MSC infusion studies show normalization of albumin, total protein, and folate levels, improvement in histopathological mucosal scores, and clinical remission in 65% of treatment-refractory cases — matching outcomes of human IBD MSC trials.
Neural
Akira Pet Neural Stem Cells — Companion Animal
| Product Options |
|---|
| 10 Million Cells / 2 mL per vial |
| 25 Million Cells / 5 mL per vial |
Akira Pet Neural Stem Cells are neural-lineage progenitors derived from UCT-WJ-MSCs for veterinary neurological applications. These cells represent one of the first cGMP-grade NSC products specifically formulated for companion animals. They secrete BDNF, GDNF, and NGF, home to neural injury sites, and provide remyelination support — addressing major unmet needs in veterinary neurology.
Neurological Applications
Veterinary Neurological Applications
- Canine Cognitive Dysfunction (CCD/dog dementia) — neurogenesis, BDNF delivery
- Degenerative Myelopathy — axonal support, neuroinflammation reduction
- Intervertebral Disc Disease (IVDD) — spinal cord regeneration
- Traumatic Brain Injury (TBI) — BBB stabilization, lesion volume reduction
- Post-seizure Brain Damage — neural repair, GABAergic support
- Ataxia, Tremors, Vestibular Disease — motor circuit support